Epilepsy Gene Therapy Using an Engineered Potassium Channel.


Journal

The Journal of neuroscience : the official journal of the Society for Neuroscience
ISSN: 1529-2401
Titre abrégé: J Neurosci
Pays: United States
ID NLM: 8102140

Informations de publication

Date de publication:
17 04 2019
Historique:
received: 07 05 2018
revised: 24 12 2018
accepted: 21 01 2019
pubmed: 14 2 2019
medline: 9 6 2020
entrez: 14 2 2019
Statut: ppublish

Résumé

Refractory focal epilepsy is a devastating disease for which there is frequently no effective treatment. Gene therapy represents a promising alternative, but treating epilepsy in this way involves irreversible changes to brain tissue, so vector design must be carefully optimized to guarantee safety without compromising efficacy. We set out to develop an epilepsy gene therapy vector optimized for clinical translation. The gene encoding the voltage-gated potassium channel Kv1.1,

Identifiants

pubmed: 30755487
pii: JNEUROSCI.1143-18.2019
doi: 10.1523/JNEUROSCI.1143-18.2019
pmc: PMC6468110
doi:

Substances chimiques

Kv1.1 Potassium Channel 147173-20-4

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3159-3169

Subventions

Organisme : Medical Research Council
ID : G0802158
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0801316
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/L01095X/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R025134/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N026101/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 209807/Z/17/Z
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : G116/147
Pays : United Kingdom

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2019 Snowball et al.

Références

Epilepsia. 2003 May;44(5):673-6
pubmed: 12752466
Nat Med. 2003 Aug;9(8):1076-80
pubmed: 12858168
Science. 2003 Oct 17;302(5644):415-9
pubmed: 14564000
Mol Ther. 2004 Jan;9(1):5-13
pubmed: 14741772
Stat Med. 1992 Jun 15;11(8):1099-102
pubmed: 1496197
J Neurosci. 2004 Mar 24;24(12):3051-9
pubmed: 15044544
Nat Struct Mol Biol. 2004 Oct;11(10):950-6
pubmed: 15361858
Proc Natl Acad Sci U S A. 2004 Dec 28;101(52):18206-11
pubmed: 15608064
Cancer Gene Ther. 2006 Jan 1;13(1):99-106
pubmed: 16052229
Nat Med. 2006 Mar;12(3):348-53
pubmed: 16491086
Epilepsia. 2006 Apr;47(4):773-80
pubmed: 16650144
Mol Ther. 2006 Jul;14(1):63-8
pubmed: 16730475
Mol Ther. 2007 Jun;15(6):1106-13
pubmed: 17387333
Brain. 2008 Apr;131(Pt 4):938-44
pubmed: 18310680
N Engl J Med. 2008 May 22;358(21):2240-8
pubmed: 18441370
Hum Gene Ther. 2008 May;19(5):463-74
pubmed: 18473686
Brain. 2008 Jun;131(Pt 6):1506-15
pubmed: 18477594
Lancet Neurol. 2008 Jun;7(6):514-24
pubmed: 18485315
Curr Gene Ther. 2008 Dec;8(6):461-73
pubmed: 19075629
Gene Ther. 2009 Apr;16(4):509-20
pubmed: 19158847
Dis Model Mech. 2009 Nov-Dec;2(11-12):612-9
pubmed: 19779067
Science. 2009 Nov 6;326(5954):818-23
pubmed: 19892975
Epilepsia. 2010 May;51(5):883-90
pubmed: 20067507
Mol Ther. 2010 Sep;18(9):1731-5
pubmed: 20606642
Brain. 2010 Sep;133(9):2778-88
pubmed: 20688813
J Neuroinflammation. 2010 Nov 18;7:81
pubmed: 21087489
Lancet Neurol. 2011 Apr;10(4):309-19
pubmed: 21419704
Nat Rev Neurol. 2011 Jul 12;7(8):462-72
pubmed: 21750525
N Engl J Med. 2011 Sep 8;365(10):919-26
pubmed: 21899452
N Engl J Med. 2011 Nov 10;365(19):1801-11
pubmed: 22070477
Epilepsia. 2012 Mar;53(3):571-82
pubmed: 22292566
Hum Gene Ther. 2012 Apr;23(4):377-81
pubmed: 22424171
Sci Transl Med. 2012 Nov 21;4(161):161ra152
pubmed: 23147003
Epilepsia. 2013 Mar;54(3):495-501
pubmed: 23167828
Sci Transl Med. 2012 Dec 19;4(165):165ra163
pubmed: 23253610
J Neurol Neurosurg Psychiatry. 2013 Oct;84(10):1107-12
pubmed: 23349320
Science. 2013 Aug 23;341(6148):1233158
pubmed: 23845948
Mol Ther. 2014 Mar;22(3):567-574
pubmed: 23941813
Hum Gene Ther Methods. 2013 Dec;24(6):333-44
pubmed: 23964981
Epilepsia. 2014 Jan;55(1):167-74
pubmed: 24245512
Gene Ther. 2014 Mar;21(3):233-41
pubmed: 24401836
Lancet. 2014 Mar 29;383(9923):1138-46
pubmed: 24412048
Lancet. 2014 Mar 29;383(9923):1129-37
pubmed: 24439297
Nat Rev Neurol. 2014 May;10(5):300-4
pubmed: 24638133
Basal Ganglia. 2014 Apr 1;3(4):187-195
pubmed: 24729952
Nat Commun. 2014 May 27;5:3847
pubmed: 24866701
FEBS Lett. 2015 Jun 22;589(14):1620-34
pubmed: 25979170
Brain. 2016 Apr;139(Pt 4):1066-78
pubmed: 26912639
Hum Gene Ther Clin Dev. 2017 Jun;28(2):74-79
pubmed: 28279081
Neuroscience. 1985 Feb;14(2):375-403
pubmed: 2859548
Lancet Neurol. 2017 Sep;16(9):712-720
pubmed: 28713035
N Engl J Med. 2017 Nov 2;377(18):1713-1722
pubmed: 29091557
Nat Med. 2018 Sep;24(9):1324-1329
pubmed: 29988123
Dis Model Mech. 2018 Dec 14;11(12):
pubmed: 30467223
Electroencephalogr Clin Neurophysiol. 1972 Mar;32(3):281-94
pubmed: 4110397
Brain. 1996 Apr;119 ( Pt 2):393-407
pubmed: 8800935
Epilepsy Res. 1998 Jun;31(1):73-84
pubmed: 9696302

Auteurs

Albert Snowball (A)

Department of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, University College London, London WC1N 3BG, United Kingdom.

Elodie Chabrol (E)

Department of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, University College London, London WC1N 3BG, United Kingdom.

Robert C Wykes (RC)

Department of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, University College London, London WC1N 3BG, United Kingdom.

Tawfeeq Shekh-Ahmad (T)

Department of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, University College London, London WC1N 3BG, United Kingdom.

Jonathan H Cornford (JH)

Department of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, University College London, London WC1N 3BG, United Kingdom.

Andreas Lieb (A)

Department of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, University College London, London WC1N 3BG, United Kingdom.

Michael P Hughes (MP)

UCL School of Pharmacy, University College London, London WC1N 1AX, United Kingdom, and.

Giulia Massaro (G)

UCL School of Pharmacy, University College London, London WC1N 1AX, United Kingdom, and.

Ahad A Rahim (AA)

UCL School of Pharmacy, University College London, London WC1N 1AX, United Kingdom, and.

Kevan S Hashemi (KS)

Open Source Instruments Inc., Watertown, Massachusetts 02472.

Dimitri M Kullmann (DM)

Department of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, University College London, London WC1N 3BG, United Kingdom, d.kullmann@ucl.ac.uk m.walker@ucl.ac.uk.

Matthew C Walker (MC)

Department of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, University College London, London WC1N 3BG, United Kingdom, d.kullmann@ucl.ac.uk m.walker@ucl.ac.uk.

Stephanie Schorge (S)

Department of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, University College London, London WC1N 3BG, United Kingdom.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH